Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 210546, 13 pages
http://dx.doi.org/10.1155/2015/210546
Research Article

Active Compounds of Rhubarb Root and Rhizome in Animal Model Experiments of Focal Cerebral Ischemia

Department of Neurology, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325027, China

Received 13 March 2015; Revised 27 April 2015; Accepted 22 July 2015

Academic Editor: Honglin Luo

Copyright © 2015 Ai-ju Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Tsai, B. Thomas, and C. L. Sudlow, “Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review,” Neurology, vol. 81, no. 3, pp. 264–272, 2013. View at Publisher · View at Google Scholar
  2. G. A. Donnan, M. Fisher, M. Macleod, and S. M. Davis, “Stroke,” The Lancet, vol. 371, no. 9624, pp. 1612–1623, 2008. View at Publisher · View at Google Scholar
  3. G. Yang, Y. Wang, Y. Zeng et al., “Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010,” The Lancet, vol. 381, no. 9882, pp. 1987–2015, 2013. View at Publisher · View at Google Scholar
  4. E. C. Jauch, J. L. Saver, H. P. Adams Jr. et al., “Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 44, pp. 870–947, 2013. View at Google Scholar
  5. S. N. Chapman, P. Mehndiratta, M. C. Johansen, T. L. McMurry, K. C. Johnston, and A. M. Southerland, “Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke,” Vascular Health and Risk Management, vol. 10, pp. 75–87, 2014. View at Publisher · View at Google Scholar
  6. B. Wu, M. Liu, H. Liu et al., “Meta-analysis of traditional Chinese patent medicine for ischemic stroke,” Stroke, vol. 38, no. 6, pp. 1973–1979, 2007. View at Publisher · View at Google Scholar
  7. L. Lu, H.-Q. Li, D.-L. Fu, G.-Q. Zheng, and J.-P. Fan, “Rhubarb root and rhizome-based chinese herbal prescriptions for acute ischemic stroke: a systematic review and meta-analysis,” Complementary Therapies in Medicine, vol. 22, no. 6, pp. 1060–1070, 2014. View at Publisher · View at Google Scholar
  8. Z. Wang, P. Ma, L. Xu, C. He, Y. Peng, and P. Xiao, “Evaluation of the content variation of anthraquinone glycosides in rhubarb by UPLC-PDA,” Chemistry Central Journal, vol. 7, no. 1, article 170, 2013. View at Publisher · View at Google Scholar
  9. Y. Wang, Y.-C. Fan, C.-L. Xie, and G.-Q. Zheng, “History of post-stroke epilepsy in ancient China,” Journal of Neurology, vol. 258, no. 8, pp. 1555–1558, 2011. View at Publisher · View at Google Scholar
  10. Q. Huang, G. Lu, H. M. Shen, M. C. Chung, and C. N. Ong, “Anti-cancer properties of anthraquinones from rhubarb,” Medicinal Research Reviews, vol. 27, no. 5, pp. 609–630, 2007. View at Publisher · View at Google Scholar
  11. H. Kaur, A. Prakash, and B. Medhi, “Drug therapy in stroke: from preclinical to clinical studies,” Pharmacology, vol. 92, no. 5-6, pp. 324–334, 2013. View at Publisher · View at Google Scholar
  12. S. Y. Xu and S. Y. Pan, “The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy,” Medical Science Monitor Basic Research, vol. 19, pp. 37–45, 2013. View at Google Scholar
  13. M. Tymianski, “Novel approaches to neuroprotection trials in acute ischemic stroke,” Stroke, vol. 44, no. 10, pp. 2942–2950, 2013. View at Publisher · View at Google Scholar
  14. L. Y. Chen, H. J. Wang, X. X. Tao et al., “Neuroprotective effects of different pretreatment patterns on the rats with focal cerebral ischemia/reperfusion injury,” Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease, vol. 13, no. 3, pp. 312–314, 2015. View at Google Scholar
  15. Q. Guan, S. Liang, Z. Wang, Y. Yang, and S. Wang, “1H NMR-based metabonomic analysis of the effect of optimized rhubarb aglycone on the plasma and urine metabolic fingerprints of focal cerebral ischemia-reperfusion rats,” Journal of Ethnopharmacology, vol. 154, no. 1, pp. 65–75, 2014. View at Publisher · View at Google Scholar
  16. J. S. Li, D. Wang, J. Fang, W. Y. Zhang, J. X. Liu, and H. X. Zhou, “Effect of different-dose rhubarb aglycone on thrombosis, platelet aggregation and adhesion, and blood coagulation in rats with cerebral ischemia: comparison with aspirin and Nimodipine,” Chinese Journal of Clinical Rehabilitation, vol. 9, pp. 142–144, 2005. View at Google Scholar
  17. J. S. Li, J. X. Liu, D. Wang et al., “Study of Rhubarb aglycone on time window of thrombolysis therapy through artery in rats with thrombus-occluded cerebral ischemia,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 26, pp. 1967–1971, 2011. View at Google Scholar
  18. J. S. Li, J. X. Liu, S. W. Liang, Z. G. Liu, K. Liu, and M. H. Wang, “Effects of anthraglucorhein aglycon on apoptosis of neurocyte in cerebral ischemia in rat and related genetic expressions,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 20, pp. 155–157, 2005. View at Google Scholar
  19. J. S. Li, J. X. Liu, D. Wang, S. W. Liang, W. Y. Zhang, and J. Fang, “Rhubarb aglycone injection antagonism to inflammatory cascade reaction of rats with cerebral ischemia injury,” Chinese Pharmacological Bulletin, vol. 23, pp. 114–118, 2007. View at Google Scholar
  20. J. S. Li, J. X. Liu, J. Fang, S. W. Liang, D. Wang, and W. Y. Zhang, “Effects of rhubarb aglycone antagonising cerebral ischemic injury and influence on inflammatory factors in rats with cerebral ischemia,” Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, vol. 12, pp. 275–278, 2005. View at Google Scholar
  21. J. X. Liu, J. S. Li, S. W. Liang, K. Liu, and M. H. Wang, “Study on the protective effects of glucoside and aglycone parts of rhubarb in rats with ischemic brain injury,” Journal of Emergency in Traditional Chinese Medicine, vol. 14, pp. 158–159, 2005. View at Google Scholar
  22. J. S. Li, J. X. Liu, S. W. Liang, J. M. Zhao, K. Liu, and M. H. Wang, “Effects of glucoside and aglycone parts of rhubarb on the metabolism of free radicals in rats with ischemic brain injury,” Chinese Journal of Clinical Rehabilitation, vol. 8, pp. 7748–7750, 2004. View at Google Scholar
  23. J. S. Li, J. X. Liu, S. W. Liang, K. Liu, and M. H. Wang, “The selecting of protective role of rhubarb's effective parts in ischemic injury in rats,” Chinese Journal of Gerontology, vol. 24, pp. 1032–1034, 2004. View at Google Scholar
  24. J. X. Liu, J. S. Li, S. W. Liang, J. F. Gao, J. M. Zhao, and W. H. Zhang, “Protective effects of rhubarb aglycone and its monomers on rats with cerebral ischemia,” Journal of Henan University of Chinese Medicine, vol. 19, pp. 23–25, 2004. View at Google Scholar
  25. L. Tan, L. Y. Wang, H. Y. Xiang, and M. Li, “Study on the protective effects and mechanisms of emodin on cerebral ischemia/reperfusion injury in rats,” Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease, vol. 8, pp. 1100–1101, 2010. View at Google Scholar
  26. Z. F. Wu, C. X. Luo, J. Sun, and L. Han, “Effects of emodin on gene expression of NF-κB and ICAM-1 in cerebral tissue of rats with ischemic stroke,” Journal of Emergency in Traditional Chinese Medicine, vol. 18, pp. 934–936, 2009. View at Google Scholar
  27. D. Wang, J. Fang, J. S. Li, W. Y. Zhang, J. X. Liu, and S. W. Liang, “A comparison study on treating cerebral ischemia of rats with emodin and aloe-emodin,” Journal of Henan University of Chinese Medicine, vol. 20, pp. 20–21, 23, 2005. View at Google Scholar
  28. J. S. Li, J. X. Liu, W. H. Zhang, S. W. Liang, D. Wang, and J. Fang, “Preventive effects of Emodin on cerebral ischemia injury and expression of the inflammatory factors in rats with cerebral ischemia,” China Journal of Chinese Materia Medica, vol. 30, pp. 1939–1943, 2005. View at Google Scholar
  29. L. Y. Chen, L. K. Su, R. H. Liao, and J. Wang, “Study of the protective effects of physcion on crerbral ischemia-reperfusion injury in rats after brain ischemic preconditioning,” Medical Recapitulate, vol. 12, pp. 1086–1088, 2006. View at Google Scholar
  30. L. Mei, R. H. Liao, R. X. Liang, and J. Wang, “Protective effects of physcion preconditioning on crerbral ischemia/reperfusion injury in rats,” Journal of the Fourth Military Medical University, vol. 30, pp. 2310–2313, 2009. View at Google Scholar
  31. L. Y. Chen, R. H. Liao, L. K. Su, X. F. Li, and J. Wang, “Anti-inflammatory effects of brain ischemic preconditioning combined with physcion on crerbral ischemia/reperfusion injury in rats,” Beijing Medical Journal, vol. 29, pp. 566–567, 2007. View at Google Scholar
  32. J. Y. Song, L. Zhang, X. Q. Zhao, and Z. B. Song, “Effects of chrysophanol liposomes on apoptosis of the hippocampal neurons in mice after cerebral ischemia and reperfusion injury,” Acta Neuropharmacologica, vol. 1, no. 2, pp. 7–13, 2011. View at Google Scholar
  33. N. Zhang, X. Zhang, X. Liu et al., “Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice,” Mediators of Inflammation, vol. 2014, Article ID 370530, 12 pages, 2014. View at Publisher · View at Google Scholar
  34. M. R. Macleod, T. O'Collins, D. W. Howells, and G. A. Donnan, “Pooling of animal experimental data reveals influence of study design and publication bias,” Stroke, vol. 35, pp. 1203–1208, 2004. View at Google Scholar
  35. S. P. Murphy and A. N. Murphy, “Pre-clinical systematic review,” Journal of Neurochemistry, vol. 115, no. 4, p. 805, 2010. View at Publisher · View at Google Scholar
  36. N. Himori, H. Watanabe, N. Akaike, M. Kurasawa, J. Itoh, and Y. Tanaka, “Cerebralischemia model with conscious mice. Involvement of NMDA receptor activation andderangement of learning and memory ability,” Journal of Pharmacological Methods, vol. 23, pp. 311–327, 1990. View at Google Scholar
  37. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, “Reversible middle cerebral artery occlusion without craniectomy in rats,” Stroke, vol. 20, no. 1, pp. 84–91, 1989. View at Publisher · View at Google Scholar
  38. Y. G. Zhang, T. P. Liu, Z. Y. Qian, and D. Liu, “Influence of total saponins of Panax ginseng on infarct size and polyamine contents in rat brain after middle cerebral artery occlusion,” Chinese Journal of Pharmacology and Toxicology, vol. 8, pp. 250–255, 1994. View at Google Scholar
  39. J. H. Garcia, S. Wagner, K. F. Liu, and X. J. Hu, “Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats,” Stroke, vol. 26, no. 4, pp. 627–635, 1995. View at Publisher · View at Google Scholar
  40. E. Sena, H. B. van der Worp, D. Howells, and M. Macleod, “How can we improve the pre-clinical development of drugs for stroke?” Trends in Neurosciences, vol. 30, no. 9, pp. 433–439, 2007. View at Publisher · View at Google Scholar
  41. J. A. Lewis, “Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline,” Statistics in Medicine, vol. 18, no. 15, pp. 1903–1942, 1999. View at Publisher · View at Google Scholar
  42. P. Zhang, L. K. Su, H. M. Li, Y. C. Zhao, Z. Q. Yang, and X. Y. Cui, “Protective effects of physcion against cerebral injury induced by ischemia-reperfusion in rats,” Chinese Journal of Pathophysiology, vol. 21, pp. 1829–1833, 2005. View at Google Scholar
  43. X. R. Wang, Y. Hou, and G. P. Xue, “Influence of rhein on NO in cerebrum of cerebral ischemia reperfusion mice,” Journal of Hebei North University (Natural Science Edition), vol. 28, pp. 73–75, 2012. View at Google Scholar
  44. H. Q. Li, J. H. Li, A. J. Liu, and G. Q. Zheng, “Baihui (GV20)-based acupuncture for animal model of acute intracerebral hemorrhage: a preclinical systematic review and meta-analysis,” Acupuncture in Medicine, vol. 32, pp. 495–502, 2014. View at Google Scholar
  45. M. R. Macleod, T. O'Collins, L. L. Horky, D. W. Howells, and G. A. Donnan, “Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke,” Journal of Cerebral Blood Flow & Metabolism, vol. 25, no. 6, pp. 713–721, 2005. View at Publisher · View at Google Scholar
  46. N. A. Crossley, E. Sena, J. Goehler et al., “Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach,” Stroke, vol. 39, no. 3, pp. 929–934, 2008. View at Publisher · View at Google Scholar